Status:
COMPLETED
Myocardial Injury and Quality of Life After COVID-19
Lead Sponsor:
Voronezh Regional Clinical Consultative and Diagnostic Center
Collaborating Sponsors:
Voronezh State Medical University named after N.N. Burdenko
Charles University, Czech Republic
Conditions:
COVID-19
Myocardial Injury
Eligibility:
All Genders
18+ years
Brief Summary
In this observational study follow-up and dynamic observation will be conducted on the participants recovered from pneumonia caused by COVID-19. The main goal is an early diagnosis and detection of my...
Detailed Description
The main goal of this observational non-interventional study is the evaluation of prevalence of myocardial injury (heart injury) of the participants recovered from the novel coronavirus infectious dis...
Eligibility Criteria
Inclusion
- Adult patients of age above 18 years with diagnosed SARS-CoV-2 infection based on the PCR (polymerase chain reaction) and/or quantitative tests of IgM and IgG antibodies in serum;
- Pneumonia development confirmed by chest computed tomography;
- Negative PCR test for SARS-CoV-2 at the time of inclusion into the study;
- Stable patient state allowing outpatient follow-up;
- Signed informed consent.
Exclusion
- Absence of convincing data confirming SARS-CoV-2 infection of a participant at the time of inclusion;
- Absence of medical records regarding previous treatment of COVID-19;
- Low compliance and unwillingness to undergo defined examinations;
- Absence of informed consent.
Key Trial Info
Start Date :
September 16 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
119 Patients enrolled
Trial Details
Trial ID
NCT04794062
Start Date
September 16 2020
End Date
December 31 2021
Last Update
November 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Voronezh Region Clinical, Consultative and Diagnostic Center
Voronezh, Voronezh Oblast, Russia, 394018